Expert Perspective: Management of the Psoriatic Arthritis Patient After Failure of One Tumor Necrosis Factor Inhibitor

Expert Perspective: Management of the Psoriatic Arthritis Patient After Failure of One Tumor Necrosis Factor Inhibitor

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arthritis & rheumatology (Hoboken, N.J.) N.J.), 2023-08, Vol.75 (8), p.1312-1324
Hauptverfasser: Leung, Ying‐Ying, Kavanaugh, Arthur, Ritchlin, Christopher T.
Format: Artikel
Sprache:eng
Schlagworte:
Antirheumatic Agents - therapeutic use
Arthritis, Psoriatic - drug therapy
Humans
Psoriasis - drug therapy
Psoriatic arthritis
Treatment Outcome
Tumor Necrosis Factor Inhibitors - therapeutic use
Tumor Necrosis Factor-alpha
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1324
container_issue 8
container_start_page 1312
container_title Arthritis & rheumatology (Hoboken, N.J.)
container_volume 75
creator Leung, Ying‐Ying
Kavanaugh, Arthur
Ritchlin, Christopher T.
description
doi_str_mv 10.1002/art.42498
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2818746655</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2842809707</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3538-e1224dc94157a7a94dc0798e45f29d595fc3cdf0a63e0c8b7d45f8a66577da5d3</originalsourceid><addsrcrecordid>eNp1kUtPAjEUhRujEYIs_AOmiRtdIJ3OdDp1RwgoiQ9icD0pnTtSMg9sO6j_3o6ACxO76bnp15N770HoPCA3ASF0KI27iWgkkiPUpSGNB4wSdnzQgQg6qG_tmvgjOIkJO0WdMBY0InHcRdvJ5waMw3MwdgPK6S3c4kdZyTcooXK4zrFbAZ7b2mjptMIj41ZGO23x3NctMsodGDyVumgMtB-eK8CLpqwNfgJlauvZqVTO17NqpZfaqzN0ksvCQn9_99DrdLIY3w8enu9m49HDQIUsTAYQUBplSkQB45JL4TXhIoGI5VRkTLBchSrLiYxDICpZ8sy_JDKOGeeZZFnYQ1c7342p3xuwLi21VVAUsoK6sSlNgoRHnmcevfyDruvGVL47T0U0abfHPXW9o9rBrIE83RhdSvOVBiRt80h9HulPHp692Ds2yxKyX_KwfQ8Md8CHLuDrf6d09LLYWX4DBd2Uaw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2842809707</pqid></control><display><type>article</type><title>Expert Perspective: Management of the Psoriatic Arthritis Patient After Failure of One Tumor Necrosis Factor Inhibitor</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Alma/SFX Local Collection</source><creator>Leung, Ying‐Ying ; Kavanaugh, Arthur ; Ritchlin, Christopher T.</creator><creatorcontrib>Leung, Ying‐Ying ; Kavanaugh, Arthur ; Ritchlin, Christopher T.</creatorcontrib><identifier>ISSN: 2326-5191</identifier><identifier>EISSN: 2326-5205</identifier><identifier>DOI: 10.1002/art.42498</identifier><identifier>PMID: 36924066</identifier><language>eng</language><publisher>Boston, USA: Wiley Periodicals, Inc</publisher><subject>Antirheumatic Agents - therapeutic use ; Arthritis, Psoriatic - drug therapy ; Humans ; Psoriasis - drug therapy ; Psoriatic arthritis ; Treatment Outcome ; Tumor Necrosis Factor Inhibitors - therapeutic use ; Tumor Necrosis Factor-alpha</subject><ispartof>Arthritis &amp; rheumatology (Hoboken, N.J.), 2023-08, Vol.75 (8), p.1312-1324</ispartof><rights>2023 The Authors. published by Wiley Periodicals LLC on behalf of American College of Rheumatology.</rights><rights>2023. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3538-e1224dc94157a7a94dc0798e45f29d595fc3cdf0a63e0c8b7d45f8a66577da5d3</citedby><cites>FETCH-LOGICAL-c3538-e1224dc94157a7a94dc0798e45f29d595fc3cdf0a63e0c8b7d45f8a66577da5d3</cites><orcidid>0000-0001-8492-6342 ; 0000-0002-2602-1219 ; 0000-0001-6942-5830</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fart.42498$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fart.42498$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36924066$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Leung, Ying‐Ying</creatorcontrib><creatorcontrib>Kavanaugh, Arthur</creatorcontrib><creatorcontrib>Ritchlin, Christopher T.</creatorcontrib><title>Expert Perspective: Management of the Psoriatic Arthritis Patient After Failure of One Tumor Necrosis Factor Inhibitor</title><title>Arthritis &amp; rheumatology (Hoboken, N.J.)</title><addtitle>Arthritis Rheumatol</addtitle><subject>Antirheumatic Agents - therapeutic use</subject><subject>Arthritis, Psoriatic - drug therapy</subject><subject>Humans</subject><subject>Psoriasis - drug therapy</subject><subject>Psoriatic arthritis</subject><subject>Treatment Outcome</subject><subject>Tumor Necrosis Factor Inhibitors - therapeutic use</subject><subject>Tumor Necrosis Factor-alpha</subject><issn>2326-5191</issn><issn>2326-5205</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><recordid>eNp1kUtPAjEUhRujEYIs_AOmiRtdIJ3OdDp1RwgoiQ9icD0pnTtSMg9sO6j_3o6ACxO76bnp15N770HoPCA3ASF0KI27iWgkkiPUpSGNB4wSdnzQgQg6qG_tmvgjOIkJO0WdMBY0InHcRdvJ5waMw3MwdgPK6S3c4kdZyTcooXK4zrFbAZ7b2mjptMIj41ZGO23x3NctMsodGDyVumgMtB-eK8CLpqwNfgJlauvZqVTO17NqpZfaqzN0ksvCQn9_99DrdLIY3w8enu9m49HDQIUsTAYQUBplSkQB45JL4TXhIoGI5VRkTLBchSrLiYxDICpZ8sy_JDKOGeeZZFnYQ1c7342p3xuwLi21VVAUsoK6sSlNgoRHnmcevfyDruvGVL47T0U0abfHPXW9o9rBrIE83RhdSvOVBiRt80h9HulPHp692Ds2yxKyX_KwfQ8Md8CHLuDrf6d09LLYWX4DBd2Uaw</recordid><startdate>202308</startdate><enddate>202308</enddate><creator>Leung, Ying‐Ying</creator><creator>Kavanaugh, Arthur</creator><creator>Ritchlin, Christopher T.</creator><general>Wiley Periodicals, Inc</general><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7T5</scope><scope>7TM</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-8492-6342</orcidid><orcidid>https://orcid.org/0000-0002-2602-1219</orcidid><orcidid>https://orcid.org/0000-0001-6942-5830</orcidid></search><sort><creationdate>202308</creationdate><title>Expert Perspective: Management of the Psoriatic Arthritis Patient After Failure of One Tumor Necrosis Factor Inhibitor</title><author>Leung, Ying‐Ying ; Kavanaugh, Arthur ; Ritchlin, Christopher T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3538-e1224dc94157a7a94dc0798e45f29d595fc3cdf0a63e0c8b7d45f8a66577da5d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antirheumatic Agents - therapeutic use</topic><topic>Arthritis, Psoriatic - drug therapy</topic><topic>Humans</topic><topic>Psoriasis - drug therapy</topic><topic>Psoriatic arthritis</topic><topic>Treatment Outcome</topic><topic>Tumor Necrosis Factor Inhibitors - therapeutic use</topic><topic>Tumor Necrosis Factor-alpha</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Leung, Ying‐Ying</creatorcontrib><creatorcontrib>Kavanaugh, Arthur</creatorcontrib><creatorcontrib>Ritchlin, Christopher T.</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Wiley Online Library Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Arthritis &amp; rheumatology (Hoboken, N.J.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Leung, Ying‐Ying</au><au>Kavanaugh, Arthur</au><au>Ritchlin, Christopher T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expert Perspective: Management of the Psoriatic Arthritis Patient After Failure of One Tumor Necrosis Factor Inhibitor</atitle><jtitle>Arthritis &amp; rheumatology (Hoboken, N.J.)</jtitle><addtitle>Arthritis Rheumatol</addtitle><date>2023-08</date><risdate>2023</risdate><volume>75</volume><issue>8</issue><spage>1312</spage><epage>1324</epage><pages>1312-1324</pages><issn>2326-5191</issn><eissn>2326-5205</eissn><cop>Boston, USA</cop><pub>Wiley Periodicals, Inc</pub><pmid>36924066</pmid><doi>10.1002/art.42498</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0001-8492-6342</orcidid><orcidid>https://orcid.org/0000-0002-2602-1219</orcidid><orcidid>https://orcid.org/0000-0001-6942-5830</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2326-5191
ispartof Arthritis & rheumatology (Hoboken, N.J.), 2023-08, Vol.75 (8), p.1312-1324
issn 2326-5191
2326-5205
language eng
recordid cdi_proquest_miscellaneous_2818746655
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Alma/SFX Local Collection
subjects Antirheumatic Agents - therapeutic use
Arthritis, Psoriatic - drug therapy
Humans
Psoriasis - drug therapy
Psoriatic arthritis
Treatment Outcome
Tumor Necrosis Factor Inhibitors - therapeutic use
Tumor Necrosis Factor-alpha
title Expert Perspective: Management of the Psoriatic Arthritis Patient After Failure of One Tumor Necrosis Factor Inhibitor
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T12%3A00%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expert%20Perspective:%20Management%20of%20the%20Psoriatic%20Arthritis%20Patient%20After%20Failure%20of%20One%20Tumor%20Necrosis%20Factor%20Inhibitor&rft.jtitle=Arthritis%20&%20rheumatology%20(Hoboken,%20N.J.)&rft.au=Leung,%20Ying%E2%80%90Ying&rft.date=2023-08&rft.volume=75&rft.issue=8&rft.spage=1312&rft.epage=1324&rft.pages=1312-1324&rft.issn=2326-5191&rft.eissn=2326-5205&rft_id=info:doi/10.1002/art.42498&rft_dat=%3Cproquest_cross%3E2842809707%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2842809707&rft_id=info:pmid/36924066&rfr_iscdi=true